CoChat

Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome

Open access
Fakih, Marwan, Ouyang, Ching, Wang, Chongkai, Tu, Travis Yiwey, Gozo, Maricel C., Cho, May, Sy, Marvin, Longmate, Jeffrey A., Lee, Peter P. · 2019 · Journal of Clinical Investigation

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Abstract

The prognostic value of immune cell infiltration within the tumor microenvironment (TME) has been extensively investigated via histological and genomic approaches. Based on the positive prognostic value of T cell infiltration, Immunoscore has been developed and validated for predicting risk of recurrence for colorectal cancer (CRC). Also, association between a consensus T helper 1 (Th-1) immune response and favorable clinical outcomes has been observed across multiple cancer types. Here, we reanalyzed public genomic data sets from The Cancer Genome Atlas (TCGA) and NCBI Gene Expression Omnibus (NCBI-GEO) and performed multispectral immunohistochemistry (IHC) on a cohort of colorectal tumors. We identified and characterized a risk group, representing approximately 10% of CRC patients, with high intratumoral CD8+ T cell infiltration, but poor prognosis. These tumors included both microsatellite instable (MSI) and stable (MSS) phenotypes and had a high density of tumor-associated macrophages (TAMs) that expressed CD274 (programmed death-ligand 1 [PD-L1]), TGF-β activation, and an immune overdrive signature characterized by the overexpression of immune response and checkpoint genes. Our findings illustrate that CRC patients may have poor prognosis despite high CD8+ T cell infiltration and provide CD274 as a simple biomarker for identifying these patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci127046

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Mandrekar JN, Mandrekar SJ, Cha SS. Cutpoint determination methods in survival analysis using SAS. Paper presented at the 28th SAS Users Group International Conference (SUGI). March 30-April 2, 2003; Seattle, WA. https://support.sas.com/ resources/papers/proceedings/proceedings/ sugi28/261-28.pdf. Accessed August 1, 2019.

Cited by

See all 89

Metadata

Authors
Fakih, M., Ouyang, C., Wang, C., Tu, T. Y., Gozo, M. C., Cho, M., Sy, M., Longmate, J. A., & Lee, P. P.
Affiliations
City Of Hope National Medical Center (US)
Corresponding author
  • Fakih, Marwan
  • Lee, Peter P.
Venue
Journal of Clinical Investigation
Published
2019-09-16
Volume
129
Issue
10
Pages
4464-4476
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2972895479
Cited by
84
References
65
Citations by year
2026: 1 · 2025: 8 · 2024: 14 · 2023: 12 · 2022: 14 · 2021: 18 · 2020: 17
FWCI
5.12
Type
journal article
Language
en
Open access
Licence
public-domain
Locations
  • Journal of Clinical Investigation (publishedVersion, public-domain)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Comprehensive Cancer Center, City of Hope (Fakih, Lee Start up funds)
  • National Cancer Institute (P30CA33572)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords
colorectal cancer, CD8+ T cell infiltration, tumor microenvironment, PD-L1, tumor-associated macrophages, TGF-beta activation, microsatellite instability, prognostic factors, immune checkpoint genes, immune response genes, T cell exhaustion
MeSH terms
Humans, Immunohistochemistry, Macrophages, Melanoma, Phenotype, Prognosis, Risk Factors, Biomarkers, Tumor, Colorectal Neoplasms, Cohort Studies, Gene Expression, Lymphocytes, Tumor-Infiltrating, CD8 Antigens, CD8-Positive T-Lymphocytes, Databases, Genetic, Microsatellite Instability, B7-H1 Antigen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.